Duvakitug

N/A

Report date: 2026/05/23 20:00:57

Base Information

Drug NameDuvakitug
Drug Alias NameTEV-48574TEV-'574TEV'574SAR447189SAR-447189 +[7
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Tumor necrosis factor superfamily member 15
TargetsTumor necrosis factor superfamily member 15
Therapy Area/IndicationsAsthmaCrohn DiseaseColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[28
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCrohn DiseaseColitis, Ulcerative
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A